Activating Community Support for Substance Users
Substance Use Disorders
About this trial
This is an interventional treatment trial for Substance Use Disorders focused on measuring Drug-free community support, Methadone maintenance, Social networks
Eligibility Criteria
Inclusion Criteria (for the ATS participant):
- ATS treatment participation of more than 4-weeks
- Submission of at least one drug-positive urine sample
- Expressed willingness to include a drug-free support person in treatment
Exclusion Criteria (for the ATS participant):
- Pregnancy
- Acute medical problem that requires immediate and intense medical management (e.g., AIDS defining illness; unstable diabetes)
- Presence of a formal thought disorder, delusions, hallucinations, or imminent risk of harm to self or others
- Unable to read.
Exclusion Criteria (for the CSPs)
- Submission of a drug-positive urine sample
- Pregnancy
- Acute medical problem that requires immediate and intense medical management (e.g., AIDS defining illness; unstable diabetes)
- Presence of a formal thought disorder, delusions, hallucinations, or imminent risk of harm to self or others
- Unable to read.
Sites / Locations
- Johns Hopkins Bayview Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Community Support Intervention
Standard Care
Participants randomized to this condition will be scheduled to attend a 12-week (1x/wk for one hour) manual-guided Community Support Intervention Group, which requires methadone maintenance treatment (MMT) participants to attend the group with a drug-free family member or friend (community support person; CSP).
Participants randomized to this condition will be scheduled to attend a 12-week (1x/wk for one hour) manual-guided Substance Use Disorder Educational Group as an attention-control for the intervention described in the experimental condition.